Five independent shRNAs against MAP17 were used and two shRNAs (sh-MAP17-#3 and sh-MAP17-#5) led to a > 60% reduction of MAP17 protein expression in both SMMC-7721 and HCC-LM3 cells (Fig. 2a). The gene discussed is PDZK1IP1; the disease is hepatocellular carcinoma.